Literature DB >> 23677064

Impact of obesity on ventricular size and function in children, adolescents and adults with Tetralogy of Fallot after initial repair.

Shiraz A Maskatia1, Joseph A Spinner, Arni C Nutting, Timothy C Slesnick, Rajesh Krishnamurthy, Shaine A Morris.   

Abstract

Obesity is epidemic in congenital heart disease, with reported rates of 16% to 26% in children and 54% in adults. The aim of this study was to evaluate the impact of obesity on ventricular function and size in patients after initial repair for tetralogy of Fallot (TOF). Cardiac magnetic resonance studies in normal-weight (body mass index percentile <85th) and obese (body mass index percentile ≥95th) children and adults with repaired tetralogy of Fallot were reviewed. The left ventricular ejection fraction, the right ventricular ejection fraction, left and right ventricular end-diastolic volumes indexed to actual body surface area, to height, and to body surface area using ideal body weight were evaluated in 36 obese patients and 72 age-matched normal-weight patients. Compared with normal-weight patients, obese patients had lower right ventricular ejection fractions (mean 46 ± 9% vs 51 ± 7%, p = 0.003) and left ventricular ejection fractions (mean 57 ± 9% vs 61 ± 6%, p = 0.017), higher right ventricular end-diastolic volumes indexed to height (mean 160 ± 59 vs 135 ± 41 ml/m, p = 0.015) and left ventricular end-diastolic volumes indexed to height (mean 86 ± 25 vs 70 ± 20 ml/m, p = 0.001), and higher right ventricular end-diastolic volumes indexed to ideal body weight (mean 166 ± 55 vs 144 ± 38 ml/m², p = 0.020) and left ventricular end-diastolic volumes indexed to ideal body weight (mean 90 ± 22 vs 75 ± 15 ml/m², p <0.001). In conclusion, obesity is a modifiable risk factor associated with worsened biventricular systolic function and biventricular dilation in patients with repaired tetralogy of Fallot. The standard method of indexing ventricular volumes using actual body surface area may underestimate volume load in obese patients.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23677064     DOI: 10.1016/j.amjcard.2013.04.030

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Repaired tetralogy of Fallot with coexisting unrepaired partial anomalous pulmonary venous connection is associated with diminished right ventricular ejection fraction and more severe right ventricular dilation.

Authors:  Sherwin S Chan; Kevin K Whitehead; Timothy S Kim; Gregory L Fu; Marc S Keller; Mark A Fogel; Matthew A Harris
Journal:  Pediatr Radiol       Date:  2015-05-03

2.  Growth and Obesity Among Older Single Ventricle Patients Presenting for Fontan Conversion.

Authors:  Lindsay R Freud; Gregory Webster; John M Costello; Sabrina Tsao; Karen Rychlik; Carl L Backer; Barbara J Deal
Journal:  World J Pediatr Congenit Heart Surg       Date:  2015-10

Review 3.  Cardiometabolic risk in obese children.

Authors:  Stephanie T Chung; Anthony U Onuzuruike; Sheela N Magge
Journal:  Ann N Y Acad Sci       Date:  2018-01       Impact factor: 5.691

4.  Effect of Weight Extremes on Ventricular Volumes and Myocardial Strain in Repaired Tetralogy of Fallot as Measured by CMR.

Authors:  Scott A Simpson; Suzanne L Field; Meng Xu; Benjamin R Saville; David A Parra; Jonathan H Soslow
Journal:  Pediatr Cardiol       Date:  2017-12-14       Impact factor: 1.655

5.  High Overweight and Obesity in Fontan Patients: A 20-Year History.

Authors:  Stephanie T Chung; Borah Hong; Lance Patterson; Christopher J Petit; J Nina Ham
Journal:  Pediatr Cardiol       Date:  2015-09-16       Impact factor: 1.655

6.  Lean body mass is the strongest anthropometric predictor of left ventricular mass in the obese paediatric population.

Authors:  James R Shea; Melissa H Henshaw; Janet Carter; Shahryar M Chowdhury
Journal:  Cardiol Young       Date:  2020-03-16       Impact factor: 1.093

7.  Normalization of glomerular filtration rate in obese children.

Authors:  Liane Correia-Costa; Franz Schaefer; Alberto Caldas Afonso; Manuela Bustorff; João Tiago Guimarães; António Guerra; Henrique Barros; Ana Azevedo
Journal:  Pediatr Nephrol       Date:  2016-03-23       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.